Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Twenty patients of mild to moderate degree of arsenical palmer keratosis will be treated with garlic oil capsule orally for 12 weeks to examine its effectiveness in reducing body arsenic load and clinical symptoms. Similar treatment with similar number of arsenic exposed controls and healthy volunteers will be included for comparison.
Thousands of Bangladeshi are suffering from arsenic-induced keratosis affecting palms and soles. Palmer keratosis, particularly in young female, affects the socioeconomic condition. Till today there is no effective treatment.
Twenty patients of mild to moderate degree of arsenical palmer keratosis will be treated with garlic oil in soft capsule (10 mg/day) orally for 12 weeks. Similar treatment will be given to 20 arsenic exposed controls and 20 healthy volunteers for comparison. The aim of this study is to examine the effectiveness of oral administration of garlic oil to reduce body arsenic load and clinical symptoms of arsenical palmer keratosis.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients of palmer arsenical keratosis | Experimental | One soft capsule of garlic oil (10 mg) daily for 12 weeks |
|
| Arsenic exposed controls | Active Comparator | One soft capsule of garlic oil (10 mg) daily for 12 weeks |
|
| Heathy volunteers | Active Comparator | One soft capsule of garlic oil (10 mg) daily for 12 weeks |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Garlic oil | Dietary Supplement | Oral administration |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in the clinical symptom of keratosis in palm | 0 week (baseline) to 12 weeks (end) |
| Measure | Description | Time Frame |
|---|---|---|
| Change in biochemical parameters (blood sugar, cholesterol and transaminase) after treatment | 0 week (baseline), 12 weeks (end) | |
| Adverse effects following treament | 0 week (baseline), 12 weeks (end) |
Not provided
Inclusion Criteria (Patients):
Inclusion Criteria (Arsenic exposed controls):
Inclusion Criteria (Healthy volunteers):
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mir Misbahuddin, MBBS, PhD | Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Bangabandhu Sheikh Mujib Medical University | Dhaka | Bangladesh |
Not provided
| ID | Term |
|---|---|
| D007642 | Keratosis |
| ID | Term |
|---|---|
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C038491 | allyl sulfide |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Change in the amount of arsenic in nail | 0 week (baseline), 20 weeks (end) |